文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Research in the genetics of pheochromocytoma and paraganglioma: a bibliometric analysis from 2002 to 2022.

作者信息

Li Lei, Guan Lihua, Tang Yueming, Zou Yutong, Zhong Jian, Qiu Ling

机构信息

Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, People's Republic of China.

State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing, 100730, People's Republic of China.

出版信息

Clin Exp Med. 2023 Nov;23(7):3969-3980. doi: 10.1007/s10238-023-01049-6. Epub 2023 Apr 27.


DOI:10.1007/s10238-023-01049-6
PMID:37103653
Abstract

Over the past two decades, there has been a significant growth in articles focusing on the genetics of pheochromocytoma and paraganglioma (PPGL). We used bibliometric methods to investigate the historical changes and trend in PPGL research. There was a total of 1263 articles published in English from 2002 to 2022 included in our study. The number of annual publications and citations in this field has been increasing in the past 20 years. Furthermore, most of the publications originated from the European countries and the United States. The co-occurrence analysis showed close cooperation between different countries, institutions, or authors. The dual-map discipline analysis revealed that majority articles focused on four disciplines: #2 (Medicine, Medical, Clinical), #4 (Molecular, Biology, Immunology), #5 (Health, Nursing, Medicine), and #8 (Molecular, Biology, Genetics). The hotspot analysis revealed the keywords that have been landmark for PPGL genetics research in different time periods, and there was continued interest in gene mutations, especially on SDHX family genes. In conclusion, this study displays the current status of research and future trends in the genetics of PPGL. In future, more in-depth research should concentrate on crucial mutation genes and their specific mechanisms to assist in molecular target therapy. It is hoped that this study may help to provide directions for future research on genes and PPGL.

摘要

相似文献

[1]
Research in the genetics of pheochromocytoma and paraganglioma: a bibliometric analysis from 2002 to 2022.

Clin Exp Med. 2023-11

[2]
Risk of metastatic pheochromocytoma and paraganglioma in mutation carriers: a systematic review and updated meta-analysis.

J Med Genet. 2020-4

[3]
Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.

Endocrinol Metab (Seoul). 2020-12

[4]
Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.

J Intern Med. 2016-12

[5]
Genetic bases of pheochromocytoma and paraganglioma.

J Mol Endocrinol. 2023-4-1

[6]
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.

Best Pract Res Clin Endocrinol Metab. 2020-3-10

[7]
Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.

Biochim Biophys Acta Rev Cancer. 2024-9

[8]
Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma.

J Clin Endocrinol Metab. 2016-3

[9]
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.

Genet Med. 2018-7-16

[10]
Pheochromocytoma: When to search a germline defect?

Presse Med. 2018

引用本文的文献

[1]
Mitophagy in Alzheimer's Disease: A Bibliometric Analysis from 2007 to 2022.

J Alzheimers Dis Rep. 2024-1-29

本文引用的文献

[1]
The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study.

Front Oncol. 2022-9-16

[2]
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.

Clin Transl Oncol. 2021-10

[3]
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.

Pancreas. 2021-4-1

[4]
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.

Curr Treat Options Oncol. 2020-8-29

[5]
An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.

Best Pract Res Clin Endocrinol Metab. 2020-3-10

[6]
Therapeutic Targeting of -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid.

Clin Cancer Res. 2020-7-15

[7]
Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies.

Best Pract Res Clin Endocrinol Metab. 2019-10-24

[8]
Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?

Curr Cardiol Rep. 2019-7-31

[9]
Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma.

J Med Genet. 2019-3-15

[10]
Gain-of-function mutations in DNMT3A in patients with paraganglioma.

Genet Med. 2018-5-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索